Primary Site >> Liver Cancer

Gene >> CTLA4

Journal: Hum Immunol. 2010 Sep;71(9):888-91.
Title: CTLA-4 gene polymorphism +49 A/G contributes to genetic susceptibility to two infection-related cancers-hepatocellular carcinoma and cervical cancer.
Author: Hu, Lingmin|Liu, Jibin|Chen, Xiaojun|Zhang, Yixin|Liu, Li|Zhu, Jian|Chen, Jianguo|Shen, Hongbing|Qiang, Fulin|Hu, Zhibin
PMID: 20538028
Journal: Nan Fang Yi Ke Da Xue Xue Bao. 2010 Aug;30(8):1838-40.
Title: [Association of CTLA4 gene +49G/A polymorphism with HBV infection and HBV-related hepatocellular carcinoma in Hunan Han population].
Author: Liu, Gang|Lu, Guang-xiu
PMID: 20813679
Journal: Clin Cancer Res. 2013 Dec 15;19(24):6678-85.
Title: Hepatocellular carcinoma from an immunologic perspective.
Author: Greten, Tim F|Duffy, Austin G|Korangy, Firouzeh
PMID: 24030702
Journal: Int Microbiol. 2014 Mar;17(1):11-20.
Title: Relating the outcome of HCV infection and different host SNP polymorphisms in a Majorcan population coinfected with HCV-HIV and treated with pegIFN-RBV.
Author: Matas, Marina|Picornell, Antonia|Cifuentes, Carmen|Payeras, Antoni|Homar, Francesc|Gonzalez-Candelas, Fernando|Lopez-Labrador, F Xavier|Moya, Andres|Ramon, Cori|Castro, Jose A
PMID: 25296442
Journal: Immunol Cell Biol. 2016 Apr;94(4):388-99.
Title: Hepatoma cell-derived leptin downregulates the immunosuppressive function of regulatory T-cells to enhance the anti-tumor activity of CD8+ T-cells.
Author: Wei, Renxiong|Hu, Yaoren|Dong, Feibo|Xu, Xiaozhen|Hu, Airong|Gao, Guosheng
PMID: 26639061
Journal: J Hepatol. 2017 Mar;66(3):545-551.
Title: Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma.
Author: Duffy, Austin G|Ulahannan, Susanna V|Makorova-Rusher, Oxana|Rahma, Osama|Wedemeyer, Heiner|Pratt, Drew|Davis, Jeremy L|Hughes, Marybeth S|Heller, Theo|ElGindi, Mei|Uppala, Ashish|Korangy, Firouzeh|Kleiner, David E|Figg, William D|Venzon, David|Steinberg,
PMID: 27816492
Journal: Gastroenterology. 2017 Oct;153(4):1107-1119.e10.
Title: Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Author: Zhou, Guoying|Sprengers, Dave|Boor, Patrick P C|Doukas, Michail|Schutz, Hannah|Mancham, Shanta|Pedroza-Gonzalez, Alexander|Polak, Wojciech G|de Jonge, Jeroen|Gaspersz, Marcia|Dong, Haidong|Thielemans, Kris|Pan, Qiuwei|IJzermans, Jan N M|Bruno, Marco J|Kwe
PMID: 28648905
Journal: Oncotarget. 2017 Jul 18;8(32):52061-52071.
Title: Therapeutic vaccine to cure large mouse hepatocellular carcinomas.
Author: Han, Zhen|Yang, De|Trivett, Anna|Oppenheim, Joost J
PMID: 28881713
Journal: Int J Mol Med. 2018 Aug;42(2):713-725.
Title: Multilayered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/betacatenin signaling activation (Review).
Author: Katoh, Masaru
PMID: 29786110
Journal: Oncoimmunology. 2018 Apr 25;7(7):e1448332.
Title: Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer.
Author: Zhou, Guoying|Noordam, Lisanne|Sprengers, Dave|Doukas, Michail|Boor, Patrick P C|van Beek, Adriaan A|Erkens, Remco|Mancham, Shanta|Grunhagen, Dirk|Menon, Anand G|Lange, Johan F|Burger, Pim J W A|Brandt, Alexandra|Galjart, Boris|Verhoef, Cornelis|Kwekkeboo
PMID: 29900067
Journal: Pathologe. 2018 Nov;39(6):556-562.
Title: [Liver injury induced by immune checkpoint inhibitor-therapy : Example of an immune-mediated drug side effect].
Author: Straub, B K|Ridder, D A|Schad, A|Loquai, C|Schattenberg, J M
PMID: 30310977